I think the market is evaluating BRN based on a realistic price for an eventual take over (which in turn englobes both past R&S efforts/costs and future market share/potential revenues). I truly believe that it does not any sense to try to evaluate Brainchip based on 2021 revenues. It would be stupid don't you agree?
1st Correction started 01/20/22, page-134
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $454.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $2.351M | 9.583M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 212207 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 372207 | 12 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
-0.005 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.0¢ | 24.0¢ | 7464422 | ||
| Last updated 15.58pm 03/05/2024 ? | |||||
| BRN (ASX) Chart |